Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Exp Neurol ; 343: 113783, 2021 09.
Article in English | MEDLINE | ID: mdl-34119482

ABSTRACT

DYT1 dystonia is a debilitating movement disorder characterized by repetitive, unintentional movements and postures. The disorder has been linked to mutation of the TOR1A/DYT1 gene encoding torsinA. Convergent evidence from studies in humans and animal models suggest that striatal medium spiny neurons and cholinergic neurons are important in DYT1 dystonia. What is not known is how torsinA dysfunction in these specific cell types contributes to the pathophysiology of DYT1 dystonia. In this study we sought to determine whether torsinA dysfunction in cholinergic neurons alone is sufficient to generate the sensorimotor dysfunction and brain changes associated with dystonia, or if torsinA dysfunction in a broader subset of cell types is needed. We generated two genetically modified mouse models, one with selective Dyt1 knock-out from dopamine-2 receptor expressing neurons (D2KO) and one where only cholinergic neurons are impacted (Ch2KO). We assessed motor deficits and performed in vivo 11.1 T functional MRI to assess sensory-evoked brain activation and connectivity, along with diffusion MRI to assess brain microstructure. We found that D2KO mice showed greater impairment than Ch2KO mice, including reduced sensory-evoked brain activity in key regions of the sensorimotor network, and altered functional connectivity of the striatum that correlated with motor deficits. These findings suggest that (1) the added impact of torsinA dysfunction in medium spiny and dopaminergic neurons of the basal ganglia generate more profound deficits than the dysfunction of cholinergic neurons alone, and (2) that sensory network impairments are linked to motor deficits in DYT1 dystonia.


Subject(s)
Brain/metabolism , Dystonia Musculorum Deformans/metabolism , Locomotion/physiology , Molecular Chaperones/metabolism , Nerve Net/metabolism , Animals , Brain/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/genetics , Gene Knockdown Techniques/methods , Male , Mice , Mice, Knockout , Molecular Chaperones/genetics , Nerve Net/diagnostic imaging
2.
Rinsho Shinkeigaku ; 60(8): 520-526, 2020 Aug 07.
Article in Japanese | MEDLINE | ID: mdl-32641633

ABSTRACT

A 46 year-old man with schizophrenia had taken several anti-psychotic drugs since 25 years of age. From ~35 years of age, he noticed occasional neck torsion to the left, and later an ataxic gait; both symptoms gradually worsened. On admission, the patient was taking olanzapine (5 mg/day) and biperiden hydrochloride (1 mg/day) because his schizophrenia was well controlled. His parents were not consanguineous, and there was no family history of neuropsychiatric diseases. On neurological examination, he showed mild cognitive impairment, saccadic eye pursuit with horizontal gaze nystagmus, mild dysarthria, dystonic posture and movement of the neck, incoordination of both hands, and an ataxic gait. Deep tendon reflexes were normal except for the patellar tendon reflex, which was exaggerated bilaterally. Pathological reflexes were negative and there was no sign of rigidity, sensory disturbance or autonomic dysfunction. Ophthalmological examinations detected thinning of the outer macula lutea in both eyes, indicative of macular dystrophy. After admission, all anti-psychotic drugs were ceased, but his dystonia was unchanged. Levodopa and trihexyphenidyl hydrochloride were not effective. General blood, urine and cerebrospinal fluid examinations showed no abnormalities. Brain MRI showed cerebellar atrophy and bilateral symmetrical thalamic lesions without brainstem atrophy or abnormal signals in the basal ganglia. I123-IMP SPECT also revealed a decreased blood flow in the cerebellum. Genetic screening, including whole exome sequencing conducted by the Initiative on Rare and Undiagnosed Disease identified no possible disease-causing variants. The patient's dystonia worsened and choreic movements manifested on his right hand and foot. We suspected dystonia with marked cerebellar atrophy (DYTCA), but could not exclude drug-induced dystonia. Macular dystrophy and bilateral thalamic lesions on brain MRI have not been previously described in DYTCA. Whether these features might be primarily associated with dystonia or cerebellar ataxia now remains to be determined.


Subject(s)
Antipsychotic Agents/adverse effects , Cerebellar Ataxia/etiology , Cerebellum/pathology , Dystonia Musculorum Deformans/etiology , Dystonia/etiology , Schizophrenia/complications , Schizophrenia/drug therapy , Atrophy/diagnostic imaging , Atrophy/etiology , Biperiden/adverse effects , Cerebellar Ataxia/diagnostic imaging , Cerebellum/diagnostic imaging , Dystonia/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neck , Olanzapine/adverse effects
3.
Neurobiol Dis ; 106: 124-132, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28673740

ABSTRACT

Multiple lines of evidence implicate striatal dysfunction in the pathogenesis of dystonia, including in DYT1, a common inherited form of the disease. The impact of striatal dysfunction on connected motor circuits and their interaction with other brain regions is poorly understood. Conditional knock-out (cKO) of the DYT1 protein torsinA from forebrain cholinergic and GABAergic neurons creates a symptomatic model that recapitulates many characteristics of DYT1 dystonia, including the developmental onset of overt twisting movements that are responsive to antimuscarinic drugs. We performed diffusion MRI and resting-state functional MRI on cKO mice of either sex to define abnormalities of diffusivity and functional connectivity in cortical, subcortical, and cerebellar networks. The striatum was the only region to exhibit an abnormality of diffusivity, indicating a selective microstructural deficit in cKO mice. The striatum of cKO mice exhibited widespread increases in functional connectivity with somatosensory cortex, thalamus, vermis, cerebellar cortex and nuclei, and brainstem. The current study provides the first in vivo support that direct pathological insult to forebrain torsinA in a symptomatic mouse model of DYT1 dystonia can engage genetically normal hindbrain regions into an aberrant connectivity network. These findings have important implications for the assignment of a causative region in CNS disease.


Subject(s)
Corpus Striatum/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/metabolism , Magnetic Resonance Imaging , Molecular Chaperones/metabolism , Prosencephalon/metabolism , Animals , Body Water/diagnostic imaging , Brain Mapping , Cholinergic Neurons/metabolism , Cholinergic Neurons/pathology , Corpus Striatum/metabolism , Corpus Striatum/pathology , Disease Models, Animal , Dystonia Musculorum Deformans/pathology , Female , GABAergic Neurons/metabolism , GABAergic Neurons/pathology , Male , Mice, Transgenic , Molecular Chaperones/genetics , Multimodal Imaging , Neural Pathways/diagnostic imaging , Neural Pathways/metabolism , Neural Pathways/pathology , Prosencephalon/diagnostic imaging , Prosencephalon/pathology , Rest
4.
Mov Disord ; 31(11): 1739-1743, 2016 11.
Article in English | MEDLINE | ID: mdl-27453152

ABSTRACT

BACKGROUND: DYT1 mutation is characterized by focal to generalized dystonia and incomplete penetrance. To explore the complex perturbations in the different neural networks and the mutual interactions among them, we studied symptomatic and asymptomatic DTY1 mutation carriers by resting-state functional MRI. METHODS: A total of 7 symptomatic DYT1, 10 asymptomatic DYT1, and 26 healthy controls were considered. Resting-state functional MRI (Oxford Centre for Functional MRI of the Brain) [FMRIB] Software Library) (FSL) MELODIC, dual regression, (as a toolbox of FSL, with Nets is referred to "networks") (FSLNets) (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLNets) was performed on 9 resting-state neural networks. RESULTS: DYT1 mutation signature (symptomatic DYT1 and asymptomatic DYT1) was characterized by increased connectivity in the dorsal attention network and in the left fronto-parietal network. Functional correlates of symptomatic DYT1 patients (symptomatic DYT1 vs healthy controls) showed increased connectivity in the sensorimotor network. DISCUSSION: This study argues that DYT1 dystonia is a network disorder, with crucial nodes in sensory-motor integration of posterior parietal structures. A better characterization of cortical networks involved in dystonia is crucial for possible neurophysiological therapeutic interventions. © 2016 International Parkinson and Movement Disorder Society.


Subject(s)
Cerebral Cortex/physiopathology , Connectome/methods , Dystonia Musculorum Deformans/physiopathology , Molecular Chaperones/genetics , Adult , Cerebral Cortex/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Female , Heterozygote , Humans , Magnetic Resonance Imaging , Male , Middle Aged
7.
Neurology ; 62(8): 1384-90, 2004 Apr 27.
Article in English | MEDLINE | ID: mdl-15111678

ABSTRACT

BACKGROUND: The authors have previously used [18F]fluorodeoxyglucose (FDG) PET to identify a reproducible pattern of regional glucose metabolism that was expressed in both manifesting and nonmanifesting carriers of the DYT1 primary dystonia mutation. OBJECTIVE: To identify specific regions that discriminated subjects according to clinical penetrance and genotype. METHODS: FDG PET was used to scan 12 nonmanifesting and 11 manifesting DYT1 gene carriers, 6 nonmanifesting DYT6 gene carriers and 7 manifesting DYT6 gene carriers, as well as 11 control subjects. The data from all five groups were analyzed with statistical parametric mapping and analysis of variance with posthoc contrasts. RESULTS: A dissociation of metabolic changes was found related to phenotype and genotype. Manifesting gene carriers of both genotypes exhibited bilateral hypermetabolism in the presupplementary motor area (Brodmann area [BA] 6) and parietal association cortices (BA 40/7) compared with the respective nonmanifesting counterparts. By contrast, genotype-specific increases in metabolism were found in the putamen, anterior cingulate (BA 24/32), and cerebellar hemispheres of DYT1 carriers. Genotype-specific changes in DYT6 involved hypometabolism of the putamen and hypermetabolism in the temporal cortex (BA 21). CONCLUSIONS: Dystonia may be associated with abnormal movement preparation caused by defective sensorimotor integration. Whereas clinical manifestations are related to cortical dysfunction, metabolic abnormalities in subcortical structures may represent trait features that are specific for individual dystonia genotypes.


Subject(s)
Brain/metabolism , Dystonia Musculorum Deformans/genetics , Dystonia Musculorum Deformans/metabolism , Penetrance , Adolescent , Adult , Aged , Brain/diagnostic imaging , Brain Mapping , Carrier Proteins/genetics , Chromosomes, Human, Pair 8/genetics , Chromosomes, Human, Pair 9/genetics , Cohort Studies , Dystonia Musculorum Deformans/diagnostic imaging , Fluorodeoxyglucose F18/pharmacokinetics , Genes, Dominant , Genotype , Heterozygote , Humans , Middle Aged , Molecular Chaperones/genetics , Tomography, Emission-Computed
9.
Zentralbl Neurochir ; 63(1): 18-22, 2002.
Article in German | MEDLINE | ID: mdl-12098079

ABSTRACT

Deep Brain Stimulation (DBS, chronic high frequency stimulation) is well established for Parkinson's disease and tremordominant movement disorders. Generalized dystonia is known as a type of movement disorder in which therapeutic options are very limited. A case of generalized dystonia is reported which was successfully treated by DBS in the Globus pallidus internus (GPI). A 26 years old male suffered from severe torsion dystonia of the lower limbs. The onset of symptoms was at age 7. It started with dystonia of the left foot. He very fast developed severe dystonia of the lower limbs. These complaints were initially treated by diazepam, later by baclofen (Lioresal ((R))) p.o em leader There was no L-DOPA response. Because of the rapid progression of the disease a cervical spinal cord stimulator was implanted with a transient success. Due to further progression of the disease the patient became wheelchair bounded and resistant for oral medication. Limited improvement of symptoms was achieved using continuous intrathecal administration of baclofen. Finally the patient was treated with 980 microgram intrathecal Baclofen (Lioresal ((R))) daily and up to 100 mg diazepam. Under these conditions the patient remained wheelchair bounded with severe lower limb dystonia. As an ultima ratio it was decided to treat the patient with stereotactic implantation of two electrodes (Medtronic 3387) and two neurostimulators (Medtronic ITREL ((R))II). The GPI was the bilateral target point. Intraoperative computerized tomography and ventriculography were used for target setting. Furthermore microrecordings were helpful to ensure the exact electrode positioning. Surgery was performed under sedation. Two weeks after surgery first improvement of symptoms was observed. Patient was able to stand with assistance. At the three months follow-up he could walk without assistance. Slight dystonic movement of the left ankle was the only remaining symptom under stimulation. The oral medication has been continuously reduced. After 6 months it was stopped. The intrathecal administered baclofen was diminished to 250 microgram daily. At the 24 months follow-up the effect of stimulation remained unchanged. However high stimulation parameters are required to maintain an optimal effect (3,5 V, 400 microseconds 145 Hz for both sides). Deep Brain Stimulation of the Globus Pallidus internus is an alternative approach for severe cases of generalized dystonia.


Subject(s)
Brain/physiology , Dystonia Musculorum Deformans/therapy , Electric Stimulation Therapy , Globus Pallidus/physiology , Neurosurgical Procedures/methods , Adult , Anti-Dyskinesia Agents/therapeutic use , Baclofen/administration & dosage , Baclofen/therapeutic use , Basal Ganglia/physiology , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/drug therapy , Electrodes, Implanted , Humans , Injections, Spinal , Male , Muscle Relaxants, Central/administration & dosage , Muscle Relaxants, Central/therapeutic use , Stereotaxic Techniques , Tomography, X-Ray Computed
10.
Spine (Phila Pa 1976) ; 26(20): 2283-8, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11598522

ABSTRACT

STUDY DESIGN: A case report of severe spinal lordosis with marked opisthotonus and retrocollis secondary to dystonia musculorum deformans is presented. OBJECTIVE: To describe a case of dystonia musculorum deformans with progressive spinal lordosis and its surgical treatment. SUMMARY OF BACKGROUND DATA: Four patients with correction of coronal spinal deformity associated with dystonia musculorum deformans have been reported in the literature. No reports of sagittal spinal deformity treated with surgical instrumentation and fusion were found. METHODS: A retrospective chart and radiographic review of a single case was conducted. RESULTS: Orthotic management and pharmacologic therapy with botulinum toxin injections were unsuccessful in controlling the deformity. Severe spinal lordosis (170 degrees ) from occiput to sacrum was corrected surgically, allowing an upright posture. CONCLUSION: Dystonia musculorum deformans is a rare condition resulting in coronal or sagittal plane deformities. When other treatment methods are unsuccessful, surgical instrumentation and arthrodesis may correct the deformity and improve function.


Subject(s)
Dystonia Musculorum Deformans/surgery , Lordosis/surgery , Spasm/surgery , Spinal Fusion/instrumentation , Adolescent , Dystonia Musculorum Deformans/complications , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/pathology , Humans , Kyphosis/diagnostic imaging , Kyphosis/etiology , Kyphosis/pathology , Kyphosis/surgery , Lordosis/diagnostic imaging , Lordosis/etiology , Lordosis/pathology , Male , Radiography , Spasm/diagnostic imaging , Spasm/etiology , Spasm/pathology , Treatment Outcome
12.
Mov Disord ; 13(2): 319-23, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9539347

ABSTRACT

There is increasing evidence that a dysfunction of the dopaminergic system may be involved in the pathogenesis of idiopathic dystonia. To visualize possible alterations of the pre- and postsynaptic side of striatal dopaminergic synapses, SPECT studies using the radiotracers [123I] epidepride and [123I] beta-CIT were performed in 10 patients with idiopathic cervical dystonia. Eleven age- and sex-matched subjects served as controls. [123I] Epidepride is a new highly affine marker of D2 receptors, and [123I] beta-CIT binds to dopamine transporters on dopaminergic nerve endings. [123I] Epidepride binding was significantly reduced in both striata of dystonia patients compared with controls (p < 0.05). In contrast, striatal [123I beta-CIT uptake did not differ from controls. We conclude that dopaminergic dysfunction in idiopathic focal dystonia mainly involves postsynaptic mechanisms and suggest a disturbance of the indirect pathway of the motor circuit resulting in a disinhibited thalamocortical stimulation.


Subject(s)
Benzamides , Carrier Proteins/physiology , Cocaine/analogs & derivatives , Contrast Media , Corpus Striatum/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Membrane Glycoproteins , Membrane Transport Proteins , Nerve Tissue Proteins , Pyrrolidines , Receptors, Dopamine/physiology , Tomography, Emission-Computed, Single-Photon , Torticollis/diagnostic imaging , Adult , Aged , Brain Mapping , Corpus Striatum/physiopathology , Dopamine Plasma Membrane Transport Proteins , Dystonia Musculorum Deformans/physiopathology , Female , Humans , Iodine Radioisotopes , Male , Middle Aged , Nerve Net/diagnostic imaging , Nerve Net/physiopathology , Torticollis/physiopathology
13.
Brain ; 118 ( Pt 6): 1473-84, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8595478

ABSTRACT

We used [18F]fluorodeoxyglucose (FDG) and PET with a statistical model of regional metabolic covariation to study brain topographic organization in idiopathic torsion dystonia (ITD). We studied 11 patients with predominantly right-sided ITD and 11 age-matched controls, and measured global, regional cerebral and normalized metabolic rates for glucose (GMR, rCMRGlc, rCMRGlc/GMR). The Scaled Subprofile Model was applied to the combined rCMRGlc dataset to identify topographic covariance profiles associated with ITD. We found that global and regional metabolic rates were normal in ITD. The SSM analysis of the combined groups of ITD patients and normals revealed a significant topographic profile characterized by relative bilateral increases in the metabolic activity of the lateral frontal and paracentral cortices, associated with relative covariate hypermetabolism of the contralateral lentiform nucleus, pons and midbrain. Subject scores for this profile correlated significantly with Fahn-Marsden disease severity ratings (r = 0.67, P < 0.02). In contrast to parkinsonism, lentiform and thalamic metabolism were dissociated in dystonia. We conclude that ITD is characterized by relative metabolic overactivity of the lentiform nucleus and premotor cortices. The presence of lentiform thalamic metabolic dissociation suggests that in this disorder hyperkinetic movements may arise through excessive activity of the direct putameno-pallidal inhibitory pathway.


Subject(s)
Brain/metabolism , Dystonia Musculorum Deformans/metabolism , Adult , Aged , Aged, 80 and over , Deoxyglucose/analogs & derivatives , Disease Progression , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/physiopathology , Female , Fluorodeoxyglucose F18 , Glucose/metabolism , Humans , Male , Middle Aged , Reference Values , Tissue Distribution , Tomography, Emission-Computed
14.
J Neurol Sci ; 111(2): 195-9, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1431986

ABSTRACT

Striatal 18F-Dopa uptake and glucose metabolism were studied by positron emission tomography with 6-L-[18F]fluorodopa and [18F]fluorodeoxyglucose, respectively, in 8 patients with idiopathic dystonia. Patients with abnormal findings on the brain CT and MRI were excluded from this study. The clinical diagnosis consisted of torsion dystonia in 3 patients, focal dystonia limited in the arm in 3 and cervical dystonia (spasmodic torticollis) in 2. The 18F-Dopa uptake, corrected by nonspecific retention in the cerebellum, at 120 min post-administration was evaluated, and increased 18F-Dopa uptake in the putamen and in the caudate head was observed in the patients with idiopathic dystonia compared to the normal controls. The striatal glucose metabolism in the patients with idiopathic dystonia showed no difference with the normal controls. These findings suggest that pathogenetic mechanism of idiopathic dystonia involves increased presynaptic activity of the dopaminergic system in the striatum.


Subject(s)
Caudate Nucleus/metabolism , Deoxyglucose/analogs & derivatives , Dihydroxyphenylalanine/analogs & derivatives , Dopamine/metabolism , Dystonia/metabolism , Glucose/metabolism , Putamen/metabolism , Adult , Caudate Nucleus/diagnostic imaging , Deoxyglucose/pharmacokinetics , Dihydroxyphenylalanine/pharmacokinetics , Dystonia/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Dystonia Musculorum Deformans/metabolism , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Putamen/diagnostic imaging , Tomography, Emission-Computed , Torticollis/diagnostic imaging , Torticollis/metabolism
15.
Semin Neurol ; 9(4): 351-9, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2701780

ABSTRACT

Reported PET findings in subcortical and corticobasal degenerations, and in dystonia, are summarized in Table 3. It can be seen that, although PET is not a diagnostic technique, clinical examination combined with PET findings can help to distinguish between the various akinetic-rigid syndromes, with the proviso that pathologic validation of many PET studies is still awaited. More importantly, PET is now providing information about the functional effects of these various subcortical degenerations, and about dystonia. It is likely that more information will become available about the nature of the functional corrections between cortex, thalamus, and basal ganglia as increasingly sophisticated activation paradigms are designed for PET studies on movement disorders.


Subject(s)
Brain Diseases/diagnostic imaging , Dystonia/diagnostic imaging , Tomography, Emission-Computed , Cerebral Cortex/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Humans , Shy-Drager Syndrome/diagnostic imaging , Supranuclear Palsy, Progressive/diagnostic imaging
17.
Clin Pediatr (Phila) ; 23(4): 232-5, 1984 Apr.
Article in English | MEDLINE | ID: mdl-6697632

ABSTRACT

We report two siblings who are suffering from a dystonic syndrome, clinically indistinguishable from idiopathic torsion dystonia (dystonia musculorum deformans) but with cranial computerized tomographic scan findings of basal ganglia lesions, similar to that reported in Wilson's disease. The occurrence of the disorder in the same sibship suggests an autosomal recessive mode of inheritance and may represent another variety of the syndrome of idiopathic torsion dystonia.


Subject(s)
Basal Ganglia Diseases/genetics , Dystonia Musculorum Deformans/genetics , Adolescent , Basal Ganglia Diseases/diagnostic imaging , Dystonia Musculorum Deformans/diagnostic imaging , Female , Humans , Male , Tomography, X-Ray Computed
19.
Riv Patol Nerv Ment ; 102(4): 181-91, 1982.
Article in Italian | MEDLINE | ID: mdl-6127781

ABSTRACT

Clinical, EMG, genetic and CT investigations were performed on 16 subjects suffering from Torsion Dystonia. We obtained the following results: i) genetically most cases were sporadic, only two could be considered autosomic dominant; ii) one of the pedigrees, with many patients, confirmed that spasmodic torticollis is not a distinct form from that of Dystonia Muscolorum Deformans; the two forms must be included in one disease called "Torsion Dystonia", as maintained by some Authors; iii) we found that the various drugs employed, rarely produced improvement, although benzodiaze4pines have given some benefit; iv) CT findings were not specific, though useful for differential diagnosis.


Subject(s)
Dystonia Musculorum Deformans/diagnosis , Adolescent , Adult , Antipsychotic Agents/therapeutic use , Child , Child, Preschool , Clonazepam/therapeutic use , Diazepam/therapeutic use , Drug Therapy, Combination , Dystonia Musculorum Deformans/diagnostic imaging , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Parasympatholytics/therapeutic use , Pedigree , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...